Diagnostic test for the detection of early stage liver cancer

Chemistry: analytical and immunological testing – Cancer

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C436S063000, C436S086000, C436S094000

Reexamination Certificate

active

08003392

ABSTRACT:
Described are methods and kits to detect early stage hepatocellular carcinoma or a change in the gradation of hepatocellular carcinoma in mammals. The diagnostic marker is based on the profiling and identification of diagnostic carbohydrates present in a body fluid, such as blood serum.

REFERENCES:
patent: 2004/0147033 (2004-07-01), Shriver et al.
patent: 2005/0112691 (2005-05-01), Callewaert et al.
patent: 2006/0014294 (2006-01-01), Contreras et al.
patent: 2008/0318332 (2008-12-01), Mechref et al.
patent: WO 2006/121892 (2006-11-01), None
patent: WO 2008/152070 (2008-12-01), None
patent: 2009/013538 (2009-01-01), None
patent: 2009/075883 (2009-06-01), None
patent: 2009/117666 (2009-09-01), None
#Callewaert et al., Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics, Nature Medicine, Nature Publishing Group, Apr. 1, 2004, pp. 429-34, vol. 10, No. 4, New York, NY, US.
#Paradis et al., Identification of a New Marker of Hepatocellular Carcinoma by Serum Protein Profiling of Patients With Chronic Liver Disease, Hepatology, 2005, pp. 40-47, vol. 41, No. 1.
#Comunale et al., Proteomic Analysis of Serum Associated Fucosylated Glycoproteins in the Development of Primary Hepatocellular Carcinoma, Journal of Proteome Research, 2006, pp. 308-15, vol. 5, No. 2.
#Liu et al., N-Glycomic Changes in Hepatocellular Carcinoma Patients with Liver Cirrhosis Induced by Hepatitis B Virus, Hepatology, 2007, pp. 1426-1435, vol. 46, No. 5.
PCT International Search Report, PCT/EP2008/057325, dated Sep. 23, 20008.
U.S. Appl. No. 12/231,168, filed Aug. 28, 2008, Contreras et al., Improved Protein Secretion in Eukaryotic Cells.
U.S. Appl. No. 11/792,203, filed Aug. 6, 2007, Chen et al., Aging Biomarker.
U.S. Appl. No. 12/225,396, filed Sep. 17, 2008, Contreras et al., Novel Vaccine Against Trypanosoma Cruzi Infection.
European Office Action of Application No. 08 760 873.3-2404; dated Nov. 3, 2010.
Response to Office action dated Feb. 24, 2011.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Diagnostic test for the detection of early stage liver cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnostic test for the detection of early stage liver cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic test for the detection of early stage liver cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2693747

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.